SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $73,375 | -8.9% | 16,415 | +52.5% | 0.00% | 0.0% |
| Q1 2021 | $80,515 | -40.7% | 10,764 | -13.9% | 0.00% | -50.0% |
| Q4 2020 | $135,679 | +22.7% | 12,505 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $110,544 | -17.1% | 12,505 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $133,303 | +83.9% | 12,505 | +2.3% | 0.00% | 0.0% |
| Q1 2020 | $72,494 | -47.4% | 12,225 | -8.0% | 0.00% | 0.0% |
| Q3 2019 | $137,940 | +414.0% | 13,289 | +358.6% | 0.00% | – |
| Q2 2019 | $26,835 | -75.7% | 2,898 | -68.7% | 0.00% | -100.0% |
| Q3 2018 | $110,251 | -99.9% | 9,257 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $94,514,000 | +60485.9% | 9,257 | -4.5% | 0.00% | +100.0% |
| Q2 2017 | $156,000 | – | 9,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |